Search This Blog

Monday, September 28, 2026

Lifecore Biomedical to be acquired by Webster Equity Partners for $6.28 per share

 

Lifecore Biomedical to be acquired by Webster Equity Partners for $6.28 per share in cash plus CVRs

  • Contingent value rights could deliver up to an additional $3.39 per share to Lifecore holders.
  • Transaction values Lifecore Biomedical at up to approximately $663.7 million including potential contingent value rights.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)